齐鲁晚报·齐鲁壹点 尚青龙 高雅洁 除了精密"大脑"，人形机器人推广的另一重要制约因素是协调流畅的行动能力。青岛钢铁侠科技有限公 司十年磨一剑，为机器人锻造最强"小脑"。以ARTROBOT系列大型双足仿人机器人为例，从初代仅能 双足行走，到如今第五代可完成端茶倒水、拧螺丝等复杂精细动作，每一步都凝聚着研发团队的心血。 "第一代ARTROBOT只有两条腿，我们的目标很简单，就是先实现稳定的双足行走。虽然面临诸多技术 难题，但团队坚持攻克。"青岛钢铁侠科技有限公司副总裁陈天祥介绍道，第五代ARTROBOT搭载的自 研"运动脑"，集成精密硬件与智能软件系统，在提升算力的同时降低功耗，为机器人的精准动作输出提 供核心支撑。"'运动脑'如同人类的小脑，体积不大却功能强大。它让机器人的每一个动作都更加精 准、流畅，极大便利了多自由度机器人的开发。" 康养领域的领跑布局 乐聚智家和钢铁侠作为引入的"生力军"，为青岛具身智能产业注入了活力。而青岛本土企业在智能机器 人领域，尤其在康养医疗领域已抢占先机。 山东卓业医疗研发的全球首台AI经皮穿刺手术导航机器人，集成3D结构光与动态感知技术，可实现亚 毫米级穿刺精度。"这台机器人 ...

Core Insights - The article highlights the rapid integration of embodied intelligence robots in various sectors in Qingdao, showcasing the city's ambition to establish a strong foothold in this emerging industry [1][10]. Group 1: Technological Advancements - Qingdao Leju Robotics has developed the humanoid robot "Kua Fu," which features advanced AI capabilities for interaction and decision-making, enhancing visitor experiences in exhibition settings [2][3]. - The ARTROBOT series by Qingdao Iron Man Technology has evolved from basic bipedal movement to complex tasks like serving tea and screwing, demonstrating significant advancements in robotic mobility and functionality [3][4]. Group 2: Medical and Rehabilitation Innovations - Shandong Zhuoye Medical has created the world's first AI percutaneous puncture navigation robot, achieving sub-millimeter precision, which is crucial for tumor intervention surgeries [4][5]. - Kangdao (Qingdao) Medical Technology focuses on AI and embodied intelligence in rehabilitation, with its exoskeleton robot aiding patients with lower limb mobility issues [4][5]. Group 3: Industry Leadership and Collaborations - Qingdao companies have achieved multiple "firsts" in the core areas of the embodied robot industry, showcasing their competitive edge [6][10]. - Guohua (Qingdao) Intelligent Equipment Co., Ltd. specializes in precision harmonic reducers, essential components for humanoid robots, and has established strategic partnerships with leading industry players [7][10]. Group 4: Corporate Involvement and Ecosystem Development - Major corporations like Haier and Hisense are heavily investing in the development of embodied intelligence robots, with Haier focusing on home service robots and Hisense on industrial automation [8][9]. - Qingdao's government is actively promoting the humanoid robot industry through action plans and funding initiatives, aiming to create a supportive ecosystem for innovation and growth [11][12]. Group 5: Future Directions and Support Mechanisms - The city is establishing a comprehensive support system encompassing technology, talent, capital, and application scenarios to enhance its competitive advantage in the industry [11][12]. - Qingdao is developing a "super scene" testing ground across various sectors, including healthcare and industrial applications, to facilitate the practical implementation of robotic technologies [12].

Core Insights - The article highlights the rapid integration of embodied intelligence robots in various sectors in Qingdao, showcasing the city's ambition to establish a strong foothold in this emerging industry [1][10]. Group 1: Technological Advancements - Qingdao Leju Robotics has developed the humanoid robot "Kua Fu," which features advanced AI capabilities for interaction and decision-making, enhancing visitor experiences in exhibition settings [2][3]. - The ARTROBOT series by Qingdao Iron Man Technology has evolved from basic bipedal movement to complex tasks like serving tea and screwing, demonstrating significant advancements in robotic action capabilities [3][4]. - The fifth generation of ARTROBOT incorporates a self-developed "motion brain," which enhances precision and fluidity in robotic movements while reducing power consumption [3][4]. Group 2: Medical and Rehabilitation Innovations - Shandong Zhuoye Medical has created the world's first AI percutaneous puncture navigation robot, achieving sub-millimeter precision, which is crucial for tumor intervention surgeries [4][5]. - Kangdao (Qingdao) Medical Technology focuses on AI and embodied intelligence in rehabilitation, with its lower limb exoskeleton robot aiding patients with mobility impairments [4][5]. Group 3: Industry Leadership and Collaborations - Qingdao enterprises have achieved multiple "firsts" in the core areas of the embodied robot industry, showcasing their competitive edge [6][10]. - Companies like Guohua (Qingdao) Intelligent Equipment and Hexagon are making significant contributions to the development of key components and digital solutions for the robotics industry [6][7]. Group 4: Government Support and Strategic Initiatives - The Qingdao government has launched action plans to support the humanoid robot industry, focusing on technology development, platform support, and ecosystem building [11][12]. - A substantial fund has been established to provide financial backing for research and production expansion, alongside talent policies to address workforce needs [11][12]. Group 5: Future Directions and Market Potential - Qingdao aims to create a comprehensive ecosystem for embodied intelligence robots, with over 60 application scenarios across various sectors, including healthcare and industrial automation [12]. - The city is positioning itself as a leader in the smart manufacturing upgrade in China, leveraging its industrial foundation, corporate dynamism, and government commitment [12].

Core Insights - A consortium led by K5 Global, Johnson & Johnson's venture capital JJDC, Bezos Expeditions, and Wellington Management has acquired a majority stake in HistoSonics for $2.25 billion, highlighting Johnson & Johnson's strategic investment in the surgical robotics sector [1][2] - The acquisition reflects a growing interest in tumor ablation technologies, particularly high-intensity focused ultrasound (HIFU), which is expected to increase its market share in global tumor ablation procedures [2][4] Company Overview - HistoSonics was founded in 2009 by engineers and doctors from the University of Michigan, with a strategic shift in 2017 towards a robotic platform under CEO Mike Blue [5] - The company achieved significant milestones, including successful human trials in 2019 and FDA De Novo approval for its Edison platform in 2023, which is designed for non-invasive liver cancer treatment [5][7] Technology and Innovation - HistoSonics combines HIFU technology with an advanced robotic platform, enhancing the precision of tumor ablation procedures while minimizing damage to surrounding healthy tissue [4][6] - The Edison Histotripsy system utilizes high-amplitude, short-pulse ultrasound to create cavitation bubbles that mechanically disrupt targeted tissues, offering a non-invasive treatment option for liver tumors [6][10] Market Potential - The global market for tumor ablation procedures is substantial, with over 300,000 procedures performed in China alone in 2021, indicating significant growth potential for HistoSonics' technology [1][4] - HistoSonics has already treated over 2,000 patients across more than 50 centers in the U.S., with plans to install an additional 50 devices by the end of the year, showcasing its competitive market presence [10] Challenges and Future Outlook - Despite the promising technology, HistoSonics faces challenges in achieving widespread clinical adoption, including the need for more extensive clinical evidence and overcoming barriers related to commercialization and reimbursement [11][12] - The trend towards automation and minimally invasive surgery in the medical field suggests a bright future for HistoSonics, as it continues to innovate at the intersection of technology and healthcare [12]

Group 1: Industry Overview - The embodied intelligent robot industry is gaining global attention as a key focus area in the technology wave [1][2] - Shandong Province, particularly Qingdao, is positioning itself as a significant innovation hub and manufacturing center for humanoid robots within its "10+1" industrial system [1] Group 2: Company Developments - Leju Zhijia (Qingdao) Robot Technology Co., Ltd. has introduced the "Kua Fu" robot, which showcases high flexibility and intelligence, capable of performing complex tasks and customizable functions [1] - Shandong Zhuoye Medical Technology Co., Ltd. has developed the world's first AI percutaneous puncture surgical navigation robot, enhancing precision in minimally invasive treatments [2] Group 3: Technological Advancements - The integration of chips, sensors, and software is crucial for the embodied intelligent robot industry, with Qingdao establishing a comprehensive industrial chain covering key components and applications [2] - Key component manufacturers like Guohua (Qingdao) Intelligent Equipment Co., Ltd. and Hexagon Intelligent Manufacturing Technology (Qingdao) Co., Ltd. are achieving advanced performance levels and providing effective solutions for humanoid robots [2] Group 4: Application Expansion - Qingdao enterprises have made significant strides in various application scenarios, with Haier launching multiple robot products for factory and home services [3] - The city has recently announced over 60 super scenarios covering children's and elderly services, smart homes, and industrial manufacturing to accelerate the commercialization of embodied intelligent robots [3]

Core Insights - The Qingdao City Embodied Intelligent Robot Ecological Development Conference outlines a clear blueprint for the development of the robot industry, emphasizing the establishment of high-end think tanks, industry development alliances, and the initiation of a 10 billion yuan fund to support the manufacturing sector's ambitions in robotics [1][12]. Industry Developments - The conference showcased various embodied intelligent robot companies, highlighting advancements in technology and the potential for robots to become emotional companions rather than mere tools [2][9]. - The collaboration between Leju Robotics and Haier has led to the development of a humanoid service robot designed for household tasks, capable of performing activities such as laundry and watering plants [3][5]. - The introduction of the AI percutaneous puncture navigation robot by Zhuoyue Medical represents a significant technological achievement, being the world's first 3D structured light tumor minimally invasive surgery robot [4][7]. Technological Advancements - The rapid development of artificial intelligence has provided new opportunities for embodied robots, allowing for more complex functionalities and interactions [6][8]. - Qingdao's infrastructure supports the growth of the robotics industry, with over 4,800 P of computing power and the cultivation of more than 50 large model products [6][7]. Challenges and Opportunities - Despite the optimism surrounding the commercialization of humanoid robots, significant challenges remain, particularly regarding the development of a general-purpose intelligent model that can function effectively in complex environments [9][10]. - The "super scene" initiative aims to create practical applications for embodied robots across various sectors, including healthcare, industrial manufacturing, and smart homes [12][13]. Strategic Initiatives - The Qingdao government is actively fostering a supportive environment for the robotics industry, including the establishment of a 10 billion yuan fund and training facilities to enhance technological validation and application [12][13]. - The formation of a strategic advisory committee and an industry alliance aims to leverage cross-disciplinary expertise to accelerate innovation and application in the embodied intelligent robot sector [13][14].